SPINACI, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 2.551
EU - Europa 2.404
AS - Asia 1.032
SA - Sud America 178
AF - Africa 29
Continente sconosciuto - Info sul continente non disponibili 5
Totale 6.199
Nazione #
US - Stati Uniti d'America 2.484
PL - Polonia 931
IT - Italia 486
RU - Federazione Russa 426
CN - Cina 345
SG - Singapore 332
BR - Brasile 139
DE - Germania 121
HK - Hong Kong 96
GB - Regno Unito 86
FR - Francia 83
UA - Ucraina 67
VN - Vietnam 60
KR - Corea 57
FI - Finlandia 51
CA - Canada 50
SE - Svezia 42
TR - Turchia 32
JP - Giappone 30
IN - India 27
IE - Irlanda 25
NL - Olanda 20
AR - Argentina 14
MX - Messico 14
AT - Austria 13
BE - Belgio 12
EC - Ecuador 11
ZA - Sudafrica 11
BD - Bangladesh 10
CZ - Repubblica Ceca 9
TW - Taiwan 8
ES - Italia 7
AE - Emirati Arabi Uniti 6
CH - Svizzera 6
CO - Colombia 6
IR - Iran 6
EU - Europa 5
LT - Lituania 5
PE - Perù 5
EG - Egitto 4
LB - Libano 4
ID - Indonesia 3
MA - Marocco 3
PK - Pakistan 3
UZ - Uzbekistan 3
BG - Bulgaria 2
DK - Danimarca 2
DZ - Algeria 2
IL - Israele 2
PH - Filippine 2
PY - Paraguay 2
RS - Serbia 2
TN - Tunisia 2
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CL - Cile 1
CM - Camerun 1
DM - Dominica 1
EE - Estonia 1
ET - Etiopia 1
GR - Grecia 1
HN - Honduras 1
JO - Giordania 1
KE - Kenya 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LV - Lettonia 1
ME - Montenegro 1
MU - Mauritius 1
MW - Malawi 1
NG - Nigeria 1
PT - Portogallo 1
SA - Arabia Saudita 1
SO - Somalia 1
TT - Trinidad e Tobago 1
Totale 6.199
Città #
Warsaw 835
Fairfield 287
Ashburn 227
Chandler 160
Woodbridge 156
Singapore 142
Houston 134
Jacksonville 129
Camerino 125
Seattle 116
Wilmington 99
Cambridge 94
Kraków 93
Boardman 89
Hong Kong 85
Ann Arbor 76
Beijing 75
Los Angeles 62
Dallas 58
New York 51
Munich 38
Seoul 38
Tongling 33
Toronto 31
Helsinki 30
Rome 29
Lawrence 27
Princeton 27
Nanjing 26
Shanghai 26
Istanbul 25
London 25
Dublin 24
Moscow 22
Ogden 22
Centro 21
San Mateo 20
The Dalles 20
Council Bluffs 19
Ho Chi Minh City 19
São Paulo 19
Buffalo 18
Milan 18
Tokyo 18
Frankfurt am Main 16
Chicago 15
Dong Ket 15
Columbus 14
Guangzhou 14
San Diego 14
San Francisco 14
Hanoi 13
Brussels 12
Santa Clara 12
Chennai 11
Nanchang 11
Turku 11
Denver 10
Kunming 10
Atlanta 9
Orem 9
Phoenix 9
Tampa 9
Johannesburg 8
Montreal 8
Osimo 8
Pescara 8
Redondo Beach 8
Brooklyn 7
Dearborn 7
Hangzhou 7
Nuremberg 7
Poplar 7
Rio de Janeiro 7
Stockholm 7
Wuhan 7
Bremen 6
Brno 6
Florence 6
Guayaquil 6
Lakeland 6
Mason City 6
Mexico City 6
Perugia 6
Salt Lake City 6
Tianjin 6
Alessandria 5
Goyang-si 5
Jiaxing 5
Jinhua 5
Manchester 5
Monte San Vito 5
Philadelphia 5
Recanati 5
Redwood City 5
Scafati 5
Shenyang 5
Vienna 5
Amsterdam 4
Boston 4
Totale 4.140
Nome #
A2AR agonists/A3R antagonists: design, synthesis, and biological evaluation of new ligands with dual activity 403
The Length and Flexibility of the 2-Substituent of 9-Ethyladenine Derivatives Modulate Affinity and Selectivity for the Human A2A Adenosine Receptor 382
Pharmacological characterization of the GPR17 receptor dual profile 351
2′,3′-O-Substituted ATP derivatives as potent antagonists of purinergic P2X3 receptors and potential analgesic agents 338
The G Protein-Coupled Receptor GPR17: Overview and Update 323
2’,3’-O-Substituted ATP derivatives as potent antagonists of purinergic P2X3 receptors and potential analgesic agents 323
GPR17 receptor modulators and their therapeutic implications: review of recent patents 276
Investigation on 2′,3′-O-Substituted ATP Derivatives and Analogs as Novel P2X3 Receptor Antagonists 251
Simulation and Comparative Analysis of Different Binding Modes of Non-nucleoside Agonists at the A2A Adenosine Receptor 248
Update on novel purinergic P2X3 and P2X2/3 receptor antagonists and their potential therapeutic applications 231
Approaches for designing and discovering purinergic drugs for gastrointestinal diseases 227
Ex-vivo absorption study of lysine R-lipoate salt, a new pharmaceutical form of R-ALA 224
New substituted 9-propyladenine derivatives as A2Aadenosine receptor antagonists 212
New sensible method to quantize the intestinal absorption of receptor ligands 208
Non-Nucleoside Agonists of the Adenosine Receptors: An Overview 198
Modifications on the amino-3,5-dicyanopyridine core to obtain multifaceted adenosine receptor ligands with antineuropathic activity 171
A3 Adenosine Receptor Antagonists with Nucleoside Structures and Their Anticancer Activity 162
Adenosine Receptors as Neuroinflammation Modulators: Role of A1 Agonists and A2A Antagonists 152
New potent and selective A1 adenosine receptor antagonists as potential tools for the treatment of gastrointestinal diseases 141
A2A Adenosine Receptor Antagonists and their Potential in Neurological Disorders 138
A2A Adenosine Receptor Antagonists: Are Triazolotriazine and Purine Scaffolds Interchangeable? 137
The Anti-Inflammatory and Pain-Relieving Effects of AR170, an Adenosine A3 Receptor Agonist, in a Rat Model of Colitis 132
Casein kinase 1delta inhibitors as promising agents for neurodegenerative disorders 117
“Dual Anta-Inhibitors” of the A2A Adenosine Receptor and Casein Kinase CK1delta: Synthesis, Biological Evaluation, and Molecular Modeling Studies 116
Adenosine A2A Receptor Antagonists: Chemistry, SARs, and Therapeutic Potential 112
Adenine derivatives as inhibitors of the casein kinase CK1delta enzyme 105
A patent review of adenosine A2B receptor antagonists (2016-present) 98
New A2A adenosine receptor antagonists: a structure-based upside-down interaction in the receptor cavity 98
Combined therapy of A1AR agonists and A2AAR antagonists in neuroinflammation 96
Adenosine A3 receptor antagonists as anti-tumor treatment in human prostate cancer: an in vitro study 89
Multipotent stromal cells from subcutaneous adipose tissue of normal weight and obese subjects: Modulation of their adipogenic differentiation by adenosine A1 receptor ligands 82
Inhibition of Prostate Cancer Cell Growth Using Antagonists of the Adenosine A3 Receptors 72
P2X3 Receptor Ligands: Structural Features and Potential Therapeutic Applications 70
Structural Investigations on 2-Amidobenzimidazole Derivatives as New Inhibitors of Protein Kinase CK1 Delta 28
Radioligands Targeting the Purinergic P2X Receptors 17
A2A Adenosine Receptor Antagonists and Their Efficacy in Rat Models of Parkinson’s Disease 15
A2A receptor antagonist 4-(2-((6-Amino-9-ethyl-8-(furan-2-yl)-9H-purin-2-yl)amino)ethyl)phenol, a promising adenosine derivative for glioblastoma treatment 8
Beyond purinergic signaling: Dual ligand approaches to multitarget drug discovery 7
Synthesis, radio-synthesis and in vitro evaluation of terminally fluorinated derivatives of HU-210 and HU-211 as novel candidate PET tracers 4
Totale 6.362
Categoria #
all - tutte 25.203
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.203


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021773 0 0 0 0 0 180 255 37 87 82 74 58
2021/2022417 31 100 13 8 9 12 35 32 41 41 50 45
2022/2023387 50 47 14 56 25 39 1 25 55 32 32 11
2023/2024398 21 23 27 23 18 27 21 43 55 20 24 96
2024/20251.458 72 25 93 68 71 73 201 321 143 87 119 185
2025/20261.101 126 134 196 345 274 26 0 0 0 0 0 0
Totale 6.362